Source: Journal of Endocrinological Investigation. Unidade: FM
Subjects: SEGUIMENTOS, EXPRESSÃO GÊNICA, NEOPLASIAS MAMÁRIAS (GENÉTICA), CARCINOMA
ABNT
CONDE, S. J. et al. Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine. Journal of Endocrinological Investigation, v. 31, n. 12, p. 1047-1051, 2008Tradução . . Disponível em: https://doi.org/10.1007/bf03345650. Acesso em: 28 abr. 2024.APA
Conde, S. J., Luvizotto, R. A., Síbio, M. T., Katayama, M. L. H., Brentani, M. M., & Nogueira, C. R. (2008). Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine. Journal of Endocrinological Investigation, 31( 12), 1047-1051. doi:10.1007/bf03345650NLM
Conde SJ, Luvizotto RA, Síbio MT, Katayama MLH, Brentani MM, Nogueira CR. Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine [Internet]. Journal of Endocrinological Investigation. 2008 ; 31( 12): 1047-1051.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/bf03345650Vancouver
Conde SJ, Luvizotto RA, Síbio MT, Katayama MLH, Brentani MM, Nogueira CR. Tamoxifen inhibits transforming growth factor-α gene expression in human breast carcinoma samples treated with triiodothyronine [Internet]. Journal of Endocrinological Investigation. 2008 ; 31( 12): 1047-1051.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/bf03345650